Along this line, peripheral neuropathy as the leading symptom has already been reported in patients with mutations in some other primary mitochondrial disease genes (e.g. SCO2, SURF1) which are commonly associated with much more severe clinical presentations or even early death. Here, SCO2 is linked to inborn mitochondrial metabolism disorder.